Description:
A drug used to treat adults with non-small cell lung cancer that has spread and has a certain mutation (change) in the MET gene. It is also being studied in the treatment of other types of cancer. Capmatinib hydrochloride blocks a protein made by the MET gene, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called Tabrecta.
